Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02370290
What this trial is testing

Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
University of Southern California 74
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Not applicableLooking for participantsNCT05231655
What this trial is testing

Ex VIvo DEtermiNed Cancer Therapy

Who this might be right for
Bladder CancerKidney CancerMelanoma+3 more
Sheffield Teaching Hospitals NHS Foundation Trust 600
Testing effectiveness (Phase 2)Looking for participantsNCT05361720
What this trial is testing

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
Vanderbilt-Ingram Cancer Center 54
Large-scale testing (Phase 3)Ended earlyNCT00126178
What this trial is testing

Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Who this might be right for
Kidney CancerRenal Cell Carcinoma
Agenus Inc. 600
Early research (Phase 1)Active Not RecruitingNCT04707248
What this trial is testing

DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

Who this might be right for
Renal Cell CarcinomaOvarian Tumor
Daiichi Sankyo 179
Not applicableStudy completedNCT02450448
What this trial is testing

The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Who this might be right for
Neoplastic Cells, Circulating
Fuda Cancer Hospital, Guangzhou 60
Not applicableStudy completedNCT07827482
What this trial is testing

Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
First Affiliated Hospital of Fujian Medical University 228
Not applicableStudy completedNCT06955910
What this trial is testing

Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

Who this might be right for
Prostate CancerBladder CancerKidney Cancer
Istituto Oncologico Veneto IRCCS 120
Not applicableUnknownNCT01711268
What this trial is testing

Sunitinib Drug Levels and Outcomes in Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Western Sydney Local Health District 35
Not applicableActive Not RecruitingNCT02978118
What this trial is testing

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

Who this might be right for
Carcinoma, Renal CellCarcinoma, Urothelial
Duke University 67
Not applicableNot Yet RecruitingNCT06844513
What this trial is testing

Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform

Who this might be right for
Prostate Cancer (Adenocarcinoma)Renal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 800
Testing effectiveness (Phase 2)Ended earlyNCT00003520
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Stage IV Kidney Cancer
Burzynski Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00006255
What this trial is testing

Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases

Who this might be right for
Kidney CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 17
Not applicableNot Yet RecruitingNCT07497958
What this trial is testing

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (RCC)Renal Function Abnormal
Sun Yat-sen University 174
Testing effectiveness (Phase 2)Looking for participantsNCT06255223
What this trial is testing

Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Who this might be right for
Renal Cell CarcinomaRadiotherapyImmune Checkpoint Inhibitor
Jinling Hospital, China 35
Testing effectiveness (Phase 2)Study completedNCT00256880
What this trial is testing

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 100
Not applicableActive Not RecruitingNCT05179824
What this trial is testing

Tempus Priority Study: A Pan-tumor Observational Study

Who this might be right for
Breast CancerProstate CancerBladder Cancer+24 more
Tempus AI 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00684996
What this trial is testing

Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Next Page